Related Experiment Videos
Neurologic complications after allogeneic bone marrow transplantation
D Gallardo1, C Ferrà, J J Berlanga
1Department of Clinical Hematology, Hospital Duran i Reynals, Barcelona, Spain.
Bone Marrow Transplantation
|December 1, 1996
Summary
Neurological complications are frequent after allogeneic bone marrow transplantation (BMT). These neurological issues, often linked to GVHD treatments, significantly increase patient morbidity and mortality.
Area of Science:
- Hematology
- Neuroscience
- Transplantation Medicine
Background:
- Allogeneic bone marrow transplantation (BMT) is a critical treatment for various hematologic and oncologic conditions.
- Neurological complications are often underestimated following BMT.
Purpose of the Study:
- To investigate the incidence and nature of neurological complications in allogeneic BMT recipients.
- To identify the primary causes and impact of these neurological manifestations.
Main Methods:
- Retrospective analysis of 27 allogeneic BMT recipients.
- Documentation of neurological symptoms, treatments, and outcomes.
Main Results:
- 37% of patients (10 out of 27) developed neurological symptoms, with 14 episodes recorded.
- Cyclosporin A and prednisone for graft-versus-host disease (GVHD) prophylaxis/treatment were frequent triggers.
- Cerebrovascular events and CNS infections were severe complications, accounting for 26% of deaths.
Conclusions:
- Neurological complications are a common and significant issue post-allogeneic BMT.
- These complications contribute substantially to patient morbidity and mortality.
- Increased vigilance for neurological symptoms is crucial in BMT care.